InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Highlights Concussion Treatment Advances at Emergencies in Medicine Conference
Oragenics (NYSE American: OGEN) announced its participation at the Emergencies in Medicine Conference, where Chief Medical Officer Dr. James Kelly presented on advancements in concussion treatment. His session focused on Oragenics' "Trigger-to-Treat" program and the development of ONP-002, an intranasal neurosteroid designed for acute concussion care. The presentation also highlighted the integration of BRAINBox Solutions’ multi-marker diagnostic platform in clinical trials to enhance concussion detection…